Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1999

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Interventions
BIOLOGICAL

therapeutic allogeneic lymphocytes

DRUG

cyclosporine

DRUG

fludarabine phosphate

DRUG

mycophenolate mofetil

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (14)

14642

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester

32804

Florida Hospital Cancer Institute, Orlando

37212

Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville

53792

University of Wisconsin Comprehensive Cancer Center, Madison

64111

Kansas City Cancer Centers - Central, Kansas City

78229

Texas Transplant Institute, San Antonio

80218

Rocky Mountain Cancer Centers - Denver Midtown, Denver

30342-4777

Blood and Marrow Transplant Group of Georgia, Atlanta

52242-1009

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

07601

Cancer Center at Hackensack University Medical Center, Hackensack

07503

St. Joseph's Hospital and Medical Center, Paterson

97239-3098

Cancer Institute at Oregon Health and Science University, Portland

75235-8590

Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

23298-0037

Massey Cancer Center at Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT00044954 - Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter